ERBB2 and metastatic malignant neoplasm in the lymph nodes: There were significant differences in age, menopause status, lymph node metastasis, and HER2 overexpression for death (P < 0.05) and Exp (B) (expose of the B coefficient), namely, 1.01, 5.28, 10.01, and 4.32, respectively.